Suppr超能文献

氯碳头孢与头孢克洛治疗女性尿路感染的比较。

Loracarbef versus cefaclor in the treatment of urinary tract infections in women.

作者信息

Iravani A

机构信息

Department of Pediatrics, College of Medicine, University of Florida, Gainesville 32610-0296.

出版信息

Antimicrob Agents Chemother. 1991 Apr;35(4):750-2. doi: 10.1128/AAC.35.4.750.

Abstract

In a double-blind, prospective, randomized study, 108 college women with acute urinary tract infections were treated for 7 days with either loracarbef (LY163892) at 200 mg once daily (n = 53) or cefaclor at 250 mg three times daily (n = 55). The cure rates at 5 to 9 days after treatment in the loracarbef and cefaclor groups were 96 and 90%, respectively. Both loracarbef and cefaclor are safe, well tolerated, and effective in the treatment of urinary tract infections in women.

摘要

在一项双盲、前瞻性、随机研究中,108名患有急性尿路感染的大学女性被给予以下两种治疗方案,为期7天:每日一次服用200毫克氯碳头孢(LY163892)(n = 53),或每日三次服用250毫克头孢克洛(n = 55)。氯碳头孢组和头孢克洛组在治疗后5至9天的治愈率分别为96%和90%。氯碳头孢和头孢克洛在治疗女性尿路感染方面均安全、耐受性良好且有效。

相似文献

5
Antibiotic therapy for urinary tract infections.
Am J Med. 1992 Jun 22;92(6A):95S-100S. doi: 10.1016/0002-9343(92)90615-i.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验